COSCIENS Biopharma
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $2,749 | $1,495 | $3,322 | $1,871 |
Gross Profit | 974 | 441 | 2,049 | 836 |
EBITDA | -2,390 | -3,250 | -5,234 | -5,366 |
EBIT | -2,677 | -3,574 | -5,626 | -5,845 |
Net Income | -2,701 | -3,643 | -6,731 | -5,755 |
Net Change In Cash | 2,749 | 1,495 | 3,322 | 1,871 |
Free Cash Flow | -4,496 | -2,487 | -3,308 | -7,910 |
Cash | 9,333 | 13,758 | 16,393 | 19,998 |
Basic Shares | 3,174 | 3,144 | 2,862 | 3,106 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $13,783 | $7,143 | $14,572 | $13,486 |
Gross Profit | 6,798 | 2,938 | 8,556 | 8,209 |
EBITDA | -13,489 | -2,842 | 6,139 | 4,180 |
EBIT | -15,096 | -4,285 | 4,671 | 2,705 |
Net Income | -15,309 | -3,485 | 3,448 | 2,639 |
Net Change In Cash | 13,783 | 7,143 | 14,572 | 13,486 |
Free Cash Flow | -15,729 | -3,304 | 4,925 | 2,197 |
Cash | 16,393 | 6,678 | 10,176 | 6,102 |
Basic Shares | 2,581 | 1,847 | 1,854 | 1,854 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-06-30 | -$0.85 |
2025-03-31 | -$1.16 |
2024-09-30 | -$1.85 |
2024-06-30 | -$0.64 |
